BALPHARMA.NSBALPHARMA.NSNSE
Loading
EBITDA as a percentage of revenue
3Y CAGR
+8.6%/yr
vs -0.8%/yr prior
5Y CAGR
-0.3%/yr
Recent acceleration
Acceleration
+9.3pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | 10.31% | -1.6% |
| 2025 | 10.48% | +11.0% |
| 2024 | 9.44% | +17.2% |
| 2023 | 8.05% | -5.5% |
| 2022 | 8.52% | -18.4% |
| 2021 | 10.44% | +265.5% |
| 2020 | 2.86% | -65.6% |
| 2019 | 8.31% | -8.1% |
| 2018 | 9.04% | +16.0% |
| 2017 | 7.80% | - |